Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 90

1.

Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.

Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, Ardau R, Arias B, Backlund L, Banzato CE, Benabarre A, Bengesser S, Bhattacharjee AK, Biernacka JM, Birner A, Brichant-Petitjean C, Bui ET, Cervantes P, Chen GB, Chen HC, Chillotti C, Cichon S, Clark SR, Colom F, Cousins DA, Cruceanu C, Czerski PM, Dantas CR, Dayer A, Étain B, Falkai P, Forstner AJ, Frisén L, Fullerton JM, Gard S, Garnham JS, Goes FS, Grof P, Gruber O, Hashimoto R, Hauser J, Herms S, Hoffmann P, Hofmann A, Jamain S, Jiménez E, Kahn JP, Kassem L, Kittel-Schneider S, Kliwicki S, König B, Kusumi I, Lackner N, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, Jaramillo CA, MacQueen G, Manchia M, Martinsson L, Mattheisen M, McCarthy MJ, McElroy SL, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Ösby U, Ozaki N, Perlis RH, Pfennig A, Reich-Erkelenz D, Rouleau GA, Schofield PR, Schubert KO, Schweizer BW, Seemüller F, Severino G, Shekhtman T, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Smoller JW, Squassina A, Stamm T, Stopkova P, Tighe SK, Tortorella A, Turecki G, Volkert J, Witt S, Wright A, Young LT, Zandi PP, Potash JB, DePaulo JR, Bauer M, Reininghaus EZ, Novák T, Aubry JM, Maj M, Baune BT, Mitchell PB, Vieta E, Frye MA, Rybakowski JK, Kuo PH, Kato T, Grigoroiu-Serbanescu M, Reif A, Del Zompo M, Bellivier F, Schalling M, Wray NR, Kelsoe JR, Alda M, Rietschel M, McMahon FJ, Schulze TG.

Lancet. 2016 Jan 21. pii: S0140-6736(16)00143-4. doi: 10.1016/S0140-6736(16)00143-4. [Epub ahead of print]

PMID:
26806518
2.

The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression.

Stamm TJ, Rampp C, Wiethoff K, Stingl J, Mössner R, O Malley G, Ricken R, Seemüller F, Keck M, Fisher R, Gaebel W, Maier W, Möller HJ, Bauer M, Adli M.

J Psychopharmacol. 2016 Jan;30(1):40-7. doi: 10.1177/0269881115620459. Epub 2015 Dec 8.

PMID:
26645208
3.

[Admission and discharge decisions in psychiatric hospitals : The 7-day cycle: analysis based on the VIPP database].

Wolff-Menzler C, Gyßer S, Große C, Häfner S, Seemüller F, Godemann F, Wiegand H, Löhr M.

Nervenarzt. 2015 Nov 12. [Epub ahead of print] German.

PMID:
26556095
4.

Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methods.

Schennach R, Möller HJ, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Musil R, Spellmann I, Riedel M.

Int J Methods Psychiatr Res. 2015 Jul 14. doi: 10.1002/mpr.1476. [Epub ahead of print]

PMID:
26178421
5.

[Calculating personnel allocation at 100 % implementation of the Psychiatry Personnel Act. Can it be done on the basis of existing routine data?].

Godemann F, Wolff-Menzler C, Löhr M, Nitschke R, Salize HJ, Seemüller F, Laengle G, Wolff J, Hauth I.

Nervenarzt. 2015 Jul;86(7):845-51. doi: 10.1007/s00115-015-4354-1. German.

PMID:
26099500
6.

[Diagnosis of Metabolic Risk Factors in Psychiatric Inpatients].

Häfner S, Wolff-Menzler C, Schulz M, Noelle R, Wiegand HF, Seemüller F, Nienaber A, Löhr M, Godemann F.

Psychiatr Prax. 2015 Apr 17. [Epub ahead of print] German.

PMID:
25891883
7.

[Incidence and Costs of 1:1 Care in Psychiatric Hospitals in Germany - A Descriptive Analysis Based on the VIPP Project Data Set.]

Nienaber A, Schulz M, Noelle R, Wiegand HF, Wolff-Menzler C, Häfner S, Seemüller F, Godemann F, Löhr M.

Psychiatr Prax. 2015 Feb 2. [Epub ahead of print] German.

PMID:
25643038
8.

What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?

Schennach R, Riedel M, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ.

Eur Psychiatry. 2015 Jan;30(1):43-50. doi: 10.1016/j.eurpsy.2014.11.001. Epub 2014 Dec 22.

PMID:
25541347
9.

Characteristics and differences in treatment outcome of inpatients with chronic vs. episodic major depressive disorders.

Köhler S, Wiethoff K, Ricken R, Stamm T, Baghai TC, Fisher R, Seemüller F, Brieger P, Cordes J, Malevani J, Laux G, Hauth I, Möller HJ, Zeiler J, Heinz A, Bauer M, Adli M.

J Affect Disord. 2015 Mar 1;173:126-33. doi: 10.1016/j.jad.2014.10.059. Epub 2014 Nov 10.

PMID:
25462406
10.

[The new payment system in psychiatry - do elderly people belong to the losers? An analysis on the basis of the VIPP1 data base].

Godemann F, Löhr M, Wiegand HF, Wolff-Menzler C, Nitschke R, Seemüller F.

Fortschr Neurol Psychiatr. 2014 Nov;82(11):634-9. doi: 10.1055/s-0034-1385266. Epub 2014 Nov 10. German.

PMID:
25383930
11.

[Long-term treatment of bipolar disorder].

Berger M, Musil R, Seemüller F.

Fortschr Neurol Psychiatr. 2014 Jun;82(6):346-58; quiz 359-60. doi: 10.1055/s-0034-1366575. Epub 2014 Jun 5. Review. German. No abstract available. Erratum in: Fortschr Neurol Psychiatr. 2013 Jun;82(6):E1.

PMID:
24901318
12.

[The Quality of Inpatient Treatment of Elderly with Major Depression].

Godemann F, Seemüller F, Schneider A, Wolff-Menzler C.

Psychiatr Prax. 2015 Jul;42(5):255-9. doi: 10.1055/s-0034-1370007. Epub 2014 May 23. German.

PMID:
24858430
13.

The predictive power of subgroups: an empirical approach to identify depressive symptom patterns that predict response to treatment.

Bühler J, Seemüller F, Läge D.

J Affect Disord. 2014 Jul;163:81-7. doi: 10.1016/j.jad.2014.03.053. Epub 2014 Apr 8.

PMID:
24836092
14.

Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors.

Seemüller F, Meier S, Obermeier M, Musil R, Bauer M, Adli M, Kronmüller K, Holsboer F, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Riedel M, Falkai P, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2014 Oct;264(7):567-75. doi: 10.1007/s00406-014-0495-7. Epub 2014 Mar 4.

PMID:
24590257
15.

Pleckstrin homology domain containing 6 protein (PLEKHA6) polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients.

Spellmann I, Rujescu D, Musil R, Meyerwas S, Giegling I, Genius J, Zill P, Dehning S, Cerovecki A, Seemüller F, Schennach R, Hartmann AM, Schäfer M, Müller N, Möller HJ, Riedel M.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 3;51:190-5. doi: 10.1016/j.pnpbp.2014.02.006. Epub 2014 Feb 25. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2015 Apr 3;58:106. Meyerwas, Sebastian [added].

PMID:
24576533
16.

DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions.

Nemeroff CB, Weinberger D, Rutter M, MacMillan HL, Bryant RA, Wessely S, Stein DJ, Pariante CM, Seemüller F, Berk M, Malhi GS, Preisig M, Brüne M, Lysaker P.

BMC Med. 2013 Sep 12;11:202. doi: 10.1186/1741-7015-11-202. Review.

17.

History, background, concepts and current use of comedication and polypharmacy in psychiatry.

Möller HJ, Seemüller F, Schennach-Wolff R, Stübner S, Rüther E, Grohmann R.

Int J Neuropsychopharmacol. 2014 Jul;17(7):983-96. doi: 10.1017/S1461145713000837. Epub 2013 Sep 18. Review.

PMID:
24044761
18.

[Risk factors for inpatient suicide].

Lieb M, Palm U, Meyer S, Sarubin N, Mokhtari-Nejad R, Riedel M, Möller HJ, Seemüller F.

Psychiatr Prax. 2014 May;41(4):195-9. doi: 10.1055/s-0033-1343267. Epub 2013 Jul 18. German.

PMID:
23868715
19.

Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report.

Manchia M, Adli M, Akula N, Ardau R, Aubry JM, Backlund L, Banzato CE, Baune BT, Bellivier F, Bengesser S, Biernacka JM, Brichant-Petitjean C, Bui E, Calkin CV, Cheng AT, Chillotti C, Cichon S, Clark S, Czerski PM, Dantas C, Zompo MD, Depaulo JR, Detera-Wadleigh SD, Etain B, Falkai P, Frisén L, Frye MA, Fullerton J, Gard S, Garnham J, Goes FS, Grof P, Gruber O, Hashimoto R, Hauser J, Heilbronner U, Hoban R, Hou L, Jamain S, Kahn JP, Kassem L, Kato T, Kelsoe JR, Kittel-Schneider S, Kliwicki S, Kuo PH, Kusumi I, Laje G, Lavebratt C, Leboyer M, Leckband SG, López Jaramillo CA, Maj M, Malafosse A, Martinsson L, Masui T, Mitchell PB, Mondimore F, Monteleone P, Nallet A, Neuner M, Novák T, O'Donovan C, Osby U, Ozaki N, Perlis RH, Pfennig A, Potash JB, Reich-Erkelenz D, Reif A, Reininghaus E, Richardson S, Rouleau GA, Rybakowski JK, Schalling M, Schofield PR, Schubert OK, Schweizer B, Seemüller F, Grigoroiu-Serbanescu M, Severino G, Seymour LR, Slaney C, Smoller JW, Squassina A, Stamm T, Steele J, Stopkova P, Tighe SK, Tortorella A, Turecki G, Wray NR, Wright A, Zandi PP, Zilles D, Bauer M, Rietschel M, McMahon FJ, Schulze TG, Alda M.

PLoS One. 2013 Jun 19;8(6):e65636. Print 2013.

20.

Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.

Cerovecki A, Musil R, Klimke A, Seemüller F, Haen E, Schennach R, Kühn KU, Volz HP, Riedel M.

CNS Drugs. 2013 Jul;27(7):545-72. doi: 10.1007/s40263-013-0079-5. Review.

PMID:
23821039
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk